Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate

Edward J. Mueller, John Coventry, Paul M. Desmond, Eric J. Zeidman, Ian M. Thompson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Prostate specific antigen (PSA) has become an important method for early detection of prostate cancer. It has been suggested that prostate specific antigen density (PSAD) may be a more efficient test for early detection than PSA alone. A series of 327 men undergoing prostate biopsy were evaluated by PSA and PSAD. When the receiver operating characteristic curves of both tests were compared, they demonstrated little improvement in the efficiency of detection with the use of PSAD. The five-fold increase in the cost of PSAD over PSA alone does not justify its inclusion in a plan for early detection for carcinoma of the prostate.

Original languageEnglish (US)
Pages (from-to)84-87
Number of pages4
JournalUrologic Oncology: Seminars and Original Investigations
Volume1
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Prostate-Specific Antigen
Prostate
Carcinoma
Antigens
Early Detection of Cancer
ROC Curve
Prostatic Neoplasms
Biopsy
Costs and Cost Analysis

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate. / Mueller, Edward J.; Coventry, John; Desmond, Paul M.; Zeidman, Eric J.; Thompson, Ian M.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 1, No. 2, 1995, p. 84-87.

Research output: Contribution to journalArticle

@article{a3a9cec9f4704b52b7b5019cf0043d58,
title = "Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate",
abstract = "Prostate specific antigen (PSA) has become an important method for early detection of prostate cancer. It has been suggested that prostate specific antigen density (PSAD) may be a more efficient test for early detection than PSA alone. A series of 327 men undergoing prostate biopsy were evaluated by PSA and PSAD. When the receiver operating characteristic curves of both tests were compared, they demonstrated little improvement in the efficiency of detection with the use of PSAD. The five-fold increase in the cost of PSAD over PSA alone does not justify its inclusion in a plan for early detection for carcinoma of the prostate.",
author = "Mueller, {Edward J.} and John Coventry and Desmond, {Paul M.} and Zeidman, {Eric J.} and Thompson, {Ian M.}",
year = "1995",
doi = "10.1016/1078-1439(95)00022-A",
language = "English (US)",
volume = "1",
pages = "84--87",
journal = "Urologic Oncology: Seminars and Original Investigations",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate

AU - Mueller, Edward J.

AU - Coventry, John

AU - Desmond, Paul M.

AU - Zeidman, Eric J.

AU - Thompson, Ian M.

PY - 1995

Y1 - 1995

N2 - Prostate specific antigen (PSA) has become an important method for early detection of prostate cancer. It has been suggested that prostate specific antigen density (PSAD) may be a more efficient test for early detection than PSA alone. A series of 327 men undergoing prostate biopsy were evaluated by PSA and PSAD. When the receiver operating characteristic curves of both tests were compared, they demonstrated little improvement in the efficiency of detection with the use of PSAD. The five-fold increase in the cost of PSAD over PSA alone does not justify its inclusion in a plan for early detection for carcinoma of the prostate.

AB - Prostate specific antigen (PSA) has become an important method for early detection of prostate cancer. It has been suggested that prostate specific antigen density (PSAD) may be a more efficient test for early detection than PSA alone. A series of 327 men undergoing prostate biopsy were evaluated by PSA and PSAD. When the receiver operating characteristic curves of both tests were compared, they demonstrated little improvement in the efficiency of detection with the use of PSAD. The five-fold increase in the cost of PSAD over PSA alone does not justify its inclusion in a plan for early detection for carcinoma of the prostate.

UR - http://www.scopus.com/inward/record.url?scp=1842371227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842371227&partnerID=8YFLogxK

U2 - 10.1016/1078-1439(95)00022-A

DO - 10.1016/1078-1439(95)00022-A

M3 - Article

AN - SCOPUS:1842371227

VL - 1

SP - 84

EP - 87

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

SN - 1078-1439

IS - 2

ER -